Sam-A Pharm (Korea) Top Management
009300 Stock | KRW 17,030 430.00 2.59% |
Sam-A Pharm employs about 287 people. The company is managed by 5 executives with a total tenure of roughly 670 years, averaging almost 134.0 years of service per executive, having 57.4 employees per reported executive. Analysis of Sam-A Pharm's management performance can provide insight into the company performance.
KukHwan Choi Insider Managing Director |
Heo Jun Insider Chief Officer |
Sam-A |
Sam-A Pharm Management Team Effectiveness
The company has return on total asset (ROA) of 0.0117 % which means that it generated a profit of $0.0117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 6.3771 %, meaning that it generated $6.3771 on every $100 dollars invested by stockholders. Sam-A Pharm's management efficiency ratios could be used to measure how well Sam-A Pharm manages its routine affairs as well as how well it operates its assets and liabilities.Sam-A Pharm Workforce Comparison
Sam A Pharm Co is rated second in number of employees category among its peers. The total workforce of Pharmaceuticals industry is presently estimated at about 1,203. Sam-A Pharm totals roughly 287 in number of employees claiming about 24% of equities listed under Pharmaceuticals industry.
Sam A Pharm Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Sam A Pharm Price Series Summation is a cross summation of Sam-A Pharm price series and its benchmark/peer.
Sam-A Pharm Notable Stakeholders
A Sam-A Pharm stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sam-A Pharm often face trade-offs trying to please all of them. Sam-A Pharm's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sam-A Pharm's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
KukHwan Choi | Managing Director | Profile | |
Heo Jun | Chief Officer | Profile | |
HyeonWu Lee | Managing Director | Profile | |
ShinJun Kang | Managing Director | Profile | |
HyeongCheol Nam | Managing Director | Profile |
About Sam-A Pharm Management Performance
The success or failure of an entity such as Sam A Pharm often depends on how effective the management is. Sam-A Pharm management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sam-A management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sam-A management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Co., Ltd operates as a pharmaceutical company in South Korea. Co., Ltd was founded in 1945 and is based in Seoul, South Korea. Sam A is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of Sam-A Pharm's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sam-A Pharm's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sam-A Pharm's management manipulating its earnings.
Sam-A Pharm Workforce Analysis
Traditionally, organizations such as Sam-A Pharm use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sam-A Pharm within its industry.Sam-A Pharm Manpower Efficiency
Return on Sam-A Pharm Manpower
Revenue Per Employee | 190.5M | |
Revenue Per Executive | 10.9B | |
Net Income Per Employee | 11.8M | |
Net Income Per Executive | 678.3M | |
Working Capital Per Employee | 228.3M | |
Working Capital Per Executive | 13.1B |
Complementary Tools for Sam-A Stock analysis
When running Sam-A Pharm's price analysis, check to measure Sam-A Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sam-A Pharm is operating at the current time. Most of Sam-A Pharm's value examination focuses on studying past and present price action to predict the probability of Sam-A Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sam-A Pharm's price. Additionally, you may evaluate how the addition of Sam-A Pharm to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |